Innovent announces preliminary results of Sintilimab at ASCO

China |  News | 0 Comment | 31 May, 2019

Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines has announced that the preliminary results of sintilimab, the anti-P...Read more

Luye Pharma's Rykindo gets NDA filing acceptance by USFDA

China |  News | 0 Comment | 30 May, 2019

Rykindo® (LY03004), Luye Pharma's innovative, independently developed Extended-Release Microspheres formulation for injection, is one step closer to going on the U.S...Read more

Tencent Miying launches AI-supported auxiliary diagnostic system

China |  News | 0 Comment | 29 May, 2019

Tencent has announced that the launch of an AI-supported auxiliary diagnostic system for conducting digital colposcopy at the Global Digital Ecosystem Summit being held in Kunming...Read more

Sihuan Pharma gets clinical trial approval from NMPA

China |  News | 0 Comment | 30 May, 2019

Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular drug manufacturer in China's prescription drug market, announced the third generation of EGFR inhibitor XZP-5...Read more

Alphamab completes $60 M Series B Financing

China |  News | 0 Comment | 29 May, 2019

Alphamab Oncology, a leading biopharmaceutical company based in China dedicated to global development of innovative biologics for cancer therapy, has completed a US$60 million Ser...Read more

Sihuan Pharm achieves new grant approval

China |  News | 0 Comment | 28 May, 2019

Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular (CCV) drug manufacturer in China's prescription drug market, announced its grant approval for "non-...Read more

Agios's Phase 3 ClarlDHy trial of TIBSOVO meet its primary endpoint

China |  News | 0 Comment | 28 May, 2019

The partner of CStone Pharmaceuticals, Agios Pharmaceuticals has announced that the global Phase 3 ClarIDHy trial of TIBSOVO (ivosidenib) in previously treated cholangiocarcinoma patie...Read more

Nanjing YiGenCloud Institute to speed up the process of China's precision medicine with AI

China |  News | 0 Comment | 29 May, 2019

 Xinjun He, Ph.D., the executive director of Nanjing YiGenCloud Institute, a leading medical big data AI company in China, described the blueprint of their China's preci...Read more

GSK announces approval of Shingrix in China

China |  News | 0 Comment | 27 May, 2019

GlaxoSmithKline has announced that the National Medical Products Administration (NMPA) has approved Shingrix for the prevention of shingles (herpes zoster) in adults aged 50 years or older....Read more

Collaboration to establish comprehensive pharma, health system

China |  News | 0 Comment | 28 May, 2019

Following 111, Inc.'s strategic partnership with Manulife-Sinochem last year, the Company has reached another milestone. On May 24, 111 and MSH, a world leader in the design and m...Read more

CPhI China opens with analysis pointing to a surge in growth in 2019

China |  News | 0 Comment | 24 May, 2019

New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets – ...Read more

Tencent Miying launches AI-supported Auxiliary Diagnostic System

China |  News | 0 Comment | 24 May, 2019

Tencent announces the launch of an AI-supported auxiliary diagnostic system for conducting digital colposcopy at the Global Digital Ecosystem Summit being held in Kunming, China. This...Read more

WuXi STA develops CDMO partnership with Dizal Pharma

China |  News | 0 Comment | 23 May, 2019

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the term...Read more

WuXi Biologics signs vaccine manufacturing contract

China |  News | 0 Comment | 21 May, 2019

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, has announced that i...Read more

Researcher proposes glaucoma screening in China to reduce blindness

China |  News | 0 Comment | 20 May, 2019

New research by Queen’s University Belfast has found that offering glaucoma screening in China could be highly cost-effective while reducing blindness among the population. The novel ...Read more

Mabpharm announces proposed listing on the Main Board of the Hong Kong Stock Exchange

China |  News | 0 Comment | 20 May, 2019

A leading biopharmaceutical company in China, Mabpharm Limited has announced that the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited.A...Read more

WuXi Biologics commences construction of center for Innovative Biologics

China |  News | 0 Comment | 17 May, 2019

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that ...Read more

CPHI reports first quarter 2019 financial results

China |  News | 0 Comment | 15 May, 2019

China Pharma Holdings, an NYSE American-listed corporation with a fully-integrated speciality pharmaceuticals subsidiary based in China has announced financial results for th...Read more